The Review Whisperer: Your patients are talking, but what are they really saying?
In this month's The Edge, Ceatus CEO David Evans, PhD, MBA discusses how to make online reviews work for you.
In this month's The Edge, Ceatus CEO David Evans, PhD, MBA discusses how to make online reviews work for you.
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.